Institute researchers are involved in a number of clinical trials which show promise for the translation of stem cell research from bench to bedside.
If you would like to find out more about clinical trials, please contact us on: enquiries@stemcells.cam.ac.uk
|
Trial Lead |
Topic | Description | More details |
|
Parkinson's disease |
Effects of OXB-102 in patients with bilateral, idiopathic Parkinson's Disease. | NCT03720418 | |
|
Parkinson's disease |
TRANSEURO open label transplant study in Parkinson's Disease. | NCT01898390 | |
|
Multiple sclerosis |
Retinoid X receptor gamma agonists in multiple sclerosis patients to regulate the differentiation of central nervous system progenitors into remyelinating oligodendrocytes. | 2104-003145-99 | |
|
Blood components |
RESTORE - recovery and survival of stem cell originated red cells - currently pending approval from the Health Research Authority. | RESTORE | |
|
Haematologic malignancies |
Dose escalation study to investigate the clinical activity of BET inhibitors in subjects with relapsed, refractory hematologic malignancies | NCT01943851 | |
| Osteoarthritis | Evaluation the efficacy of adipose derived mesenchymal stromal cells in patients with knee osteoarthritis. | NCT02838069 | |
| Myeloproliferative neoplasms | Redeployment of tamoxifen to modulate the bone marrow niche and treat myeloproliferative neoplasms | 2015-05497-38 | |
| Connatal Pelizaeus-Merzbacher Disease | Five-year long term follow-up study of a neural stem cell therapy trial for Connatal Pelizaeus-Merzbacher Disease | NCT01005004 & NCT01391637 |